Neuroprotective Agents and Cerebral Ischaemia

Neuroprotective Agents and Cerebral Ischaemia

Series edited by Ronald J. Bradley , Series edited by Robert Adron Harris , Series edited by Peter Jenner , Volume editor Richard C. Green , Volume editor Alan J. Cross

US$207.96

Free delivery worldwide

Available
Dispatched in 3 business days

When will my order arrive?

Since 1959, "International Review of Neurobiology" has been a well-known series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. This important serial is now being combined with "Neuroscience Perspectives and Methods in Neurosciences". This combination results in a series that reaches a wider audience and publishes a greater number of thematic volumes. Stroke is the third major cause of death in the western world, and recent data provide hope that treatments may soon be available. Written by world experts on the mechanisms involved in neurodegeneration, "Neuroprotective Agents and Cerebral Ischaemia" presents an up-to-date review of current research and developing therapies. This book is essential reading for all clinicians and researchers searching for neuroprotective drugs. It describes the mechanisms involved in cell death and the biochemical changes occurring during an ischaemic episode. It presents the different factors affecting the neurodegenerative process and how compounds acting on these systems may lead to novel neuroprotective agents. It reviews in vitro and in vivo models of stroke and the activity of putative neuroprotective drugs. It discusses the application of preclinical data to formulate approaches to a clinical problem. It provides detailed reviews of both completed clinical trials and those currently underway.

show more
  • Hardback | 378 pages
  • 154.9 x 231.1 x 20.3mm | 635.04g
  • 10 Jan 1997
  • Elsevier Science Publishing Co Inc
  • Academic Press Inc
  • San Diego
  • English
  • 61 b&w illustrations, index
  • 0123668409
  • 9780123668400

Other books in this category

Other people who viewed this bought:

Author Information

Alan Cross was at the MRC Clinical Research Centre, London, followed by two years as a lecturer in the Department of Physiology, University of Manchester. In 1980 he became Head of Pharmacology at the Aston Neuroscience Research Unit.

show more

Review quote

"In balance, I recommend this book as a superior volume, whose high 'power-to-weight ratio,' readability, and availability in paperback make it attractive for personal use." --TRENDS IN NEUROSCIENCES

show more